A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

Publication | Open Access

DOI Full Paper Access

275

Citations

References

2015

Year

David J. McConkey, Woonyoung Choi, Yu Shen, I.-Ling Lee, Sima P. Porten, Surena F. Matin, Ashish M. Kamat, Paul G. Corn, Randall E. Millikan, Colin P. Dinney,

European Urology

UrologyGenitourinary CancerMedicinePathologyMolecular ClassificationCancer GenomicsClinical OutcomesOncologyTumor MicroenvironmentTumor BiologyNeoadjuvant Chemotherapy